Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7248)
All Articles published online
|
Publishing Process of This Article
|
Feb 14, 2018 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin TC, Chiu YC, Chiu HC, Liu WC, Cheng PN, Chen CY, Chang TT, Wu IC. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy. World J Gastroenterol 2018; 24(6): 725-736 [PMID: 29456411 DOI: 10.3748/wjg.v24.i6.725] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i6/725.htm |
| Number | Citing Articles |
| 1 |
I-Chin Wu, Wen-Chun Liu, Yen-Cheng Chiu, Hung-Chih Chiu, Pin-Nan Cheng, Ting-Tsung Chang. Clinical Implications of Serum Hepatitis B Virus Pregenomic RNA Kinetics in Chronic Hepatitis B Patients Receiving Antiviral Treatment and Those Achieving HBsAg Loss. Microorganisms 2021; 9(6): 1146 doi: 10.3390/microorganisms9061146
|
| 2 |
Insulin Resistance Associated Disorders Pivoting Long-Term Hepatitis B Surface Antigen Decline During Entecavir Therapy. Journal of Clinical Medicine 2019; 8(11): 1892 doi: 10.3390/jcm8111892
|
| 3 |
Meng-Lan Wang, Rong Deng, En-Qiang Chen, Chuan-Min Tao, Juan Liao, Tao-You Zhou, Juan Wang, Hong Tang. Performance of serum HBcrAg in chronic hepatitis B patients with 8-year nucleos(t)ide analogs therapy. Clinics and Research in Hepatology and Gastroenterology 2019; 43(3): 301 doi: 10.1016/j.clinre.2018.10.020
|
| 4 |
Wattana Leowattana, Pathomthep Leowattana, Tawithep Leowattana. Quantitative hepatitis B core antibody and quantitative hepatitis B surface antigen: Novel viral biomarkers for chronic hepatitis B management. World Journal of Hepatology 2024; 16(4): 550-565 doi: 10.4254/wjh.v16.i4.550
|
| 5 |
Zhidan Zheng, Wei Liao, Lili Liu, Shaohang Cai, Haipeng Zhu, Sichun Yin. Effect of nucleos(t)ide analogue on serum HBsAg level in chronic hepatitis B patients: A 3-years study. Biomedicine & Pharmacotherapy 2020; 122: 109698 doi: 10.1016/j.biopha.2019.109698
|
| 6 |
Gian Paolo Caviglia, Yulia Troshina, Enrico Garro, Marcantonio Gesualdo, Serena Aneli, Giovanni Birolo, Fabrizia Pittaluga, Rossana Cavallo, Giorgio Maria Saracco, Alessia Ciancio. Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study. Journal of Clinical Medicine 2021; 10(15): 3308 doi: 10.3390/jcm10153308
|
| 7 |
Ze-Hong Huang, Gui-Yang Lu, Ling-Xian Qiu, Guo-Hua Zhong, Yue Huang, Xing-Mei Yao, Xiao-Hui Liu, Shou-Jie Huang, Ting Wu, Quan Yuan, Ying-Bin Wang, Ying-Ying Su, Jun Zhang, Ning-Shao Xia. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09413-7
|
| 8 |
Soon Kyu Lee, Soon Woo Nam, Jeong Won Jang, Jung Hyun Kwon. Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels. Diagnostics 2024; 14(5): 495 doi: 10.3390/diagnostics14050495
|